ARCHIVES

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983

DCT Adopts New Unsolicited Contract Review Procedures

May 21, 1976

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

November 30, 2012

In Brief: Candlelight Vigil At Lincoln Memorial Planned For Night Before Cancer March

March 6, 1998

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007